WT1 and glomerular function

Seminars in Cell and Developmental Biology

Volumn 14, Issue 4, 2003, Pages 233-240

  Menke, A L ^a   Schedl, A ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRE DE BIOCHIMIE   (France)

Author keywords

Glomerular sclerosis; Podocyte; Renal failure; Wilms' tumour; WT1

Indexed keywords

WT1 PROTEIN; MESSENGER RNA;

APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; GENE; GENE EXPRESSION; GENE STRUCTURE; GLOMERULUS; GLOMERULUS FILTRATION; HUMAN; KIDNEY DEVELOPMENT; KIDNEY FAILURE; KIDNEY FUNCTION; NEPHROBLASTOMA; NEPHRON; NONHUMAN; PODOCYTE; PROTEIN FUNCTION; REVIEW; ANIMAL; BIOLOGICAL MODEL; CELL DIVISION; DISEASE MODEL; KIDNEY; METABOLISM; MOUSE; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; KIDNEY FAILURE; KIDNEY GLOMERULUS; MICE; MODELS, BIOLOGICAL; RNA, MESSENGER; WILMS TUMOR; WT1 PROTEINS;

EID: 0642282020     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-9521(03)00026-0     Document Type: Article

References (73)

1. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A.et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 60:1990;509-520.
2. Gessler M., Poustka A., Cavenee W., Neve R.L., Orkin S.H., Bruns G.A.P. Homozygous deletion in Wilms' tumors of a zinc-finger gene identified by chromosome jumping. Nature. 343:1990;774-778.
3. Pelletier J., Schalling M., Buckler A., Rogers A., Haber D.A., Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5:1991;1345-1356.
4. Haber D.A., Sohn R.L., Buckler A.J., Pelletier J., Call K.M., Housman D.E. Alternative splicing genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9618-9622.
5. Morris J.F., Madden S.L., Tournay O.E., Cook D.M., Sukhatme V.P., Rauscher F.J. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene. 6:1991;2339-2348.
6. Bruening W., Pelletier J. A non-AUG translation initiation event generates novel WT1 isoform. J. Biol. Chem. 271:1996;8646-8654.
7. Scharnhorst V., Dekker P., van der Eb A.J., Jochemsen A.G. Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties. J. Biol. Chem. 274:1999;23456-23462.
8. Sharma P.M., Bowman M., Madden S.L., Rauscher F.J. III, Sukumar S. RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev. 8:1994;720-731.
9. Nachtigal M.W., Hirokawa Y., Enyeart-Van Houten D.L., Flanagan J.N., Hammer G.D., Ingraham H.A. Wilms' tumor 1 and DAX-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 93:1998;445-454.
10. Maheswaran S., Englert C., Zheng G., Lee S.B., Wong J., Harkin D.P.J.et al. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70. Genes Dev. 12:1998;1108-1120.
11. Wang W., Lee S.B., Palmer R., Ellisen L.W., Haber D.A. A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. J. Biol. Chem. 276:2001;16810-16816.
12. Davies R.C., Calvio C., Bratt E., Larsson S.H., Lamond A.I., Hastie N.D. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev. 12:1998;3217-3225.
13. Menke AL, Hastie ND. Wilms' tumor: a developmental anomaly. Tumor suppressor genes in human cancer. 1st ed. Totowa, New Jersey: Humana Press, Fisher DE; 2001. p. 307.
14. Kreidberg J.A., Sariola H., Loring J.M., Maeda M., Pelletier J., Housman D.et al. WT-1 is required for early kidney development. Cell. 74:1993;679-691.
15. Grubb G.R., Yun K., Williams B.R.G., Eccles M.R., Reeve A.E. Expression of the WT1 protein in fetal kidneys and Wilms tumors. Lab. Invest. 71:1994;472-479.
16. Birchmeier C., Meyer D., Riethmacher D. Factors controlling growth, motility, and morphogenesis of normal and malignant epithelial cells. Int. Rev. Cytol. 160:1995;221-266.
17. Lin L.F.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF A glial-cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
18. Sanchez M.P., Silos-Santiago I., Frisen J., He B., Lira S.A., Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature. 382:1996;70-73.
19. Schuchardt A., D'Agati V., Larsson-Blomberg L., Constantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret. Nature. 367:1994;380-383.
20. Dey B.R., Sukhatme V.P., Roberts A.B., Sporn M.B., Rauscher F.J. III, Kim S.J. Repression of the transforming growth factor-β1 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endocrinol. 8:1994;595-602.
21. Donovan M.J., Natoli T.A., Sainio K., Amstutz A., Jaenisch R., Sariola H.et al. Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud. Dev. Genet. 24:1999;252-262.
22. Saxen L. Organogenesis of the kidney. Cambridge: Cambridge University Press; 1987.
23. Herzlinger D., Qiao J., Cohen D., Ramakrishna N., Brown A.M.C. Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. Dev. Biol. 166:1994;815-818.
24. Sim E.U., Smith A., Szilagi E., Rae F., Ioannou P., Lindsay M.H.et al. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene. 21:2002;2948-2960.
25. Ryan G., Steele-Perkins V., Morris J.F., Rauscher F.J. III, Dressler G.R. Repression of Pax-2 by WT1 during normal kidney development. Development. 121:1995;867-875.
26. Dehbi M., Gharemani M., Lechner M., Dressler G., Pelletier J. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' Tumor suppressor gene (WT1). Oncogene. 13:1996;447-453.
27. Stark K., Vanio S., Vassileva G., McMahon A.P. Wnt-4 regulates epithelial transformation of metanephric mesenchyme in the developing kidney. Nature. 372:1994;679-683.
28. Dressler G.R., Douglass E.C. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms' tumor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1179-1183.
29. Torres M., Gomez-Pardo E., Dressler G.R., Gruss P. Pax-2 controls multiple steps of urogenital development. Development. 121:1995;4057-4065.
30. Hewitt S.M., Hamada S., McDonnell T.J., Rauscher F.J. III, Saunders G.F. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' Tumor suppressor gene WT1. Cancer Res. 55:1995;5386-5389.
31. Mugrauer G., Ekblom P. Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J. Cell Biol. 112:1991;13-25.
32. Evans G.I., Wyllie A.H., Gilber C.S., Littlewood T.D., Land H., Brooks M.et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
33. Chandler D., El-Naggar A.K., Brisbay S., Redline R.W., McDonnel T.J. Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 to renal carcinogenesis. Hum. Pathol. 25:1994;789-796.
34. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 355:1988;440-442.
35. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
36. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:1994;619-626.
37. Bates R.C., Buret A., Van Helden D.F., Horton M.A., Burns G.F. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125:1994;403-415.
38. Harrington E.A., Bennett M.R., Fanidi A., Evan G.I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:1994;3286-3295.
39. Koseki C., Herzlinger D., Al-Awqati Q. Apoptosis in metanephric development. J. Cell Biol. 119:1992;1327-1333.
40. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G.G.et al. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14:1995;4662-4675.
41. Lee S.B., Huang K., Palmer R., Truong V.B., Herzlinger D., Kolquist K.A.et al. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell. 98:1999;663-673.
42. Moore A.W., McInnes L., Kreidberg J., Hastie N., Schedl A. Yac complementation shows a requirement for WT1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development. 126:1999;1845-1857.
43. Guo J., Menke A.L., Gubler M.-C., Clarke A.R., Harrison D., Hammes A.et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum. Mol. Genet. 11:2002;651-659.
44. Coles H.S.R., Burne J.F., Raff M.C. Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development. 118:1993;777-784.
45. Trudel M., Lanoix J., Barisoni L., Blouin M.J., Desforges M., L'Italien C.et al. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186:1997;1873-1884.
46. Mendelsohn C., Batourina E., Fung S., Gilbert T., Dodd J. Stromal cells mediate retinoid-dependent functions essential for renal development. Development. 126:1999;1139-1148.
47. Dressler G.R., Wilkinson J.E., Rothenpieler U.W., Patterson L.T., Williams-Simons L., Westphal H. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature. 362:1993;65-67.
48. Doyonnas R., Kershaw D.B., Duhme C., Merkens H., Chelliah S., Graf T.et al. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J. Exp. Med. 194:2001;13-27.
49. Doublier S., Amri K., Seurin D., Moreau E., Merlet-Benichou C., Striker G.E.et al. Overexpression of human insulin-like growth factor binding protein-1 in the mouse leads to nephron deficit. Pediatr. Res. 49:2001;660-666.
50. Terzi F., Burtin M., Hekmati M., Federici P., Grimber G., Briand P.et al. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J. Clin. Invest. 106:2000;225-234.
51. Moxham C.M., Hod Y., Malbon C.C. Gi alpha 2 mediates the inhibitory regulation of adenylcyclase in vivo: analysis in transgenic mice with Gi alpha suppressed by inducible antisense RNA. Dev. Genet. 14:1993;266-273.
52. Schiffer M., Bitzer M., Roberts I.S., Kopp J.B., ten Dijke P., Mundel P.et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J. Clin. Invest. 108:2001;807-816.
53. Guyton AC. Textbook of medical physiology. 7th ed. Philadelphia: Saunders; 1986. p. 455.
54. Lenz O., Striker L.J., Jacot T.A., Elliott S.J., Killen P.D., Striker G.E. Glomerular endothelial cells synthesize collagens but little gelatinase A and B. J. Am. Soc. Nephrol. 9:1998;2040-2047.
55. Cortez P., Riser B., Yee J., Narins R.G. Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications. Nephrol. Dial. Transplant. 14:1999;1351-1354.
56. Mundel P.A., Kriz W. Structure and function of podocytes: an update. Anat. Embryol. (Berl.). 192:1995;385-397.
57. Patek C.E., Little M.H., Flemming S., Miles C., Charlieu J.P., Clarke A.R.et al. A zinc finger truncation of murine wt1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2931-2936.
58. Hammes A., Guo J.K., Lutsch G., Leheste J.R., Landrock D., Ziegler U.et al. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell. 106:2001;319-329.
59. Menke AL, Ijpenberg A, Fleming S, Ross A, Medine CN, Patek CE, et al. The WT1-heterozygous mouse: a model to study the development of glomerular sclerosis. J Pathol, in press.
60. Ruotsalainen V., Ljungberg P., Wartiovaara J., Lenkkeri U., Kestila M., Jalanko H.et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7962-7967.
61. Shih N.Y., Li J., Karpitskii V., Nguyen A., Dustin M.L., Kanagawa O.et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science. 286:1999;312-315.
62. Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A.et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24:2000;349-354.
63. Kaplan J.M., Kim S.H., North K.N., Rennke H., Correia L.A., Tong H.Q.et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 24:2000;251-256.
64. Palmer R.E., Kotsianti A., Cadman B., Boyd T., Gerald W., Haber D.A. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr. Biol. 11:2001;1805-1809.
65. Guan L.S., Liu J.J., Xu Y.H., Wang Z.Y. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function. Cancer Res. 58:1998;4180-4184.
66. Park S., Tomlinson G., Nisen P., Haber D.A. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor. Cancer Res. 53:1993;4757-4760.
67. Barbaux S., Niaudet P., Gubler M.C., Grunfeld J.P., Jaubert F., Kuttenn F.et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17:1997;467-470.
68. Barbosa A.S., Hadjiathanasiou C.G., Theodoridis C., Papathanasiou A., Tar A., Merksz M.et al. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum. Mutat. 13:1999;146-153.
69. Natoli T.A., McDonald A., Alberta J.A., Taglienti M.E., Housman D.E., Kreidberg J.A. A mammal-specific exon of WT1 is not required for development or fertility. Mol. Cell Biol. 22:2002;4433-4438.
70. Menke A.L., Clarke A.R., Leitch A., Ijpenberg A., Williamson K.A., Spraggon L.et al. Genetic interactions between the Wilms' Tumor 1 gene and the p53 gene. Cancer Res. 62:2002;6615-6620.
71. Lee G.S., Nast C.C., Peng S.C., Artishevsky A., Ihm C.G., Guillermo R.et al. Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy. Kidney Int. 53:1998;1389-1398.
72. Harrison TR. Principals of internal medicine. 14th ed. New York: McGraw-Hill; 1998. p. 1499.
73. Breslow N.E., Takashima J.R., Ritchey M.L., Strong L.C., Green D.M. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Res. 60:2000;4030-4032.